| Application no. and date | 20764910.4 (espacenet) (Federated) (European Patent Register), 20200821 | | Patent/reg. no. and date | DK/EP 4017494, 20250820 | | Publication date | 20220629 | | Priority no. and date | US 201962890697 P, 20190823, US 202063028754 P, 20200522 | | EP pub. no. and date |
EP 4017494 20220629 | | Effective date | | | Applicant/owner | Neurocrine Biosciences, Inc., 6027 Edgewood Bend Court
San Diego, CA 92130, US | | Applicant ref. no. | V494962DK00 | | Inventor | LOEWEN, Gordon Raphael, 229 N. Granados Ave.
Solana Beach, California 92075, US,
LUO, Sha Rosa, 12780 El Camino Real
San Diego, California 92130, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/4738 (2006.01) , A61K 9/00 (2006.01) , A61P 13/12 (2006.01) , A61P 25/00 (2006.01) , A61P 25/14 (2006.01) , A61P 25/16 (2006.01) , A61P 25/24 (2006.01) , A61P 25/28 (2006.01) | | Title | VMAT2-HÆMMER VALBENAZIN TIL BRUG I EN FREMGANGSMÅDE TIL BEHANDLING AF EN NEUROLOGISK ELLER PSYKIATRISK LIDELSE HOS PATIENTER MED SVÆRT NEDSAT NYREFUNKTION | | Int. application no. | US2020047392 | | Int. publication no. | WO2021041208 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
